| 000 | 01892 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516181449.0 | ||
| 264 | 0 | _c20140204 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1560-7917 | ||
| 024 | 7 |
_a10.2807/1560-7917.es2013.18.45.20630 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacDonald, E | |
| 245 | 0 | 0 |
_aOutbreak of wound botulism in people who inject drugs, Norway, October to November 2013. _h[electronic resource] |
| 260 |
_bEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin _cNov 2013 |
||
| 300 |
_a20630 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBotulinum Antitoxin _xtherapeutic use |
| 650 | 0 | 4 |
_aBotulism _xdiagnosis |
| 650 | 0 | 4 |
_aClostridium botulinum _xisolation & purification |
| 650 | 0 | 4 | _aDisease Notification |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 |
_aHeroin Dependence _xcomplications |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorway _xepidemiology |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWound Infection _xdrug therapy |
| 700 | 1 | _aArnesen, T M | |
| 700 | 1 | _aBrantsaeter, A B | |
| 700 | 1 | _aGerlyng, P | |
| 700 | 1 | _aGrepp, M | |
| 700 | 1 | _aHansen, B Å | |
| 700 | 1 | _aJonsrud, K | |
| 700 | 1 | _aLundgren, B | |
| 700 | 1 | _aMellegård, H | |
| 700 | 1 | _aMøller-Stray, J | |
| 700 | 1 | _aRønning, K | |
| 700 | 1 | _aVestrheim, D F | |
| 700 | 1 | _aVold, L | |
| 773 | 0 |
_tEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin _gvol. 18 _gno. 45 _gp. 20630 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2807/1560-7917.es2013.18.45.20630 _zAvailable from publisher's website |
| 999 |
_c23265358 _d23265358 |
||